Search

everythinglearnresearchcommunity

for

Search:↓

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Dutasteride reduces DHT more effectively than finasteride.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

Poria cocos polysaccharides and finasteride both help treat chronic nonbacterial prostatitis, but Poria cocos polysaccharides also improve gut health.